U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H29N3O4
Molecular Weight 399.4834
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of K-134

SMILES

O[C@@H]1CCCC[C@H]1N(C2CC2)C(=O)NCCCOC3=CC4=C(NC(=O)C=C4)C=C3

InChI

InChIKey=ULGNGSQNNMKROG-WOJBJXKFSA-N
InChI=1S/C22H29N3O4/c26-20-5-2-1-4-19(20)25(16-7-8-16)22(28)23-12-3-13-29-17-9-10-18-15(14-17)6-11-21(27)24-18/h6,9-11,14,16,19-20,26H,1-5,7-8,12-13H2,(H,23,28)(H,24,27)/t19-,20-/m1/s1

HIDE SMILES / InChI

Molecular Formula C22H29N3O4
Molecular Weight 399.4834
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

K-134, a 2(1H)-quinolinone derivative, is a phosphodiesterase 3 inhibitor. It has both anti-thrombotic and anti-hyperplastic activities. It was evaluated in a phase II trial in patients with peripheral artery disease and claudication.

Originator

Approval Year

PubMed

Sample Use Guides

In Vitro Use Guide
K-134 (OPC-33509) inhibited recombinant PDE3A (IC50 = 0.10 uM) and PDE3B (IC50 = 0.28 uM).
Substance Class Chemical
Record UNII
J9J6NK6W4U
Record Status Validated (UNII)
Record Version